Type 2 & other diabetes

Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study

DiabetologiaPublished Case–cohort study

Authors' conclusion

Low plasma phospholipid 17:0 concentrations may promote the progression from GAD65Ab positivity to adult-onset diabetes.

Study context

Population
EPIC-InterAct: incident adult-onset diabetes cases and a randomly selected subcohort11,124 cases
Exposure
1 SD lower plasma phospholipid odd-chain fatty acids (OCFA) by GAD65Ab status
Outcome
Incidence of adult-onset diabetes
Methodological detailsEuropean, Prentice-weighted Cox regression, adjusted
  • European
  • Prentice-weighted Cox regression
  • Adjusted

Main finding

As reported in the abstract

Adult-onset diabetes per 1 SD lower OCFA, particularly 17:0
Low OCFA, particularly 17:0
Hazard ratio (95% CI)
GAD65Ab-negative
1.55(1.48–1.64)
GAD65Ab-positive
1.69(1.34–2.13)

Per 1 SD lower OCFA, as printed

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Joint exposure: low 17:0 and high GAD65Ab positivityvs high 17:0 and GAD65Ab negativity; diabetes incidence7.51 (4.83–11.69)
Joint exposure: low 17:0 and high GAD65Ab positivity vs high 17:0 and GAD65Ab negativity; diabetes incidence — Evidence of additive interaction: proportion attributable to interaction (AP), 95% CI 0.05, 0.45
0.25

Low dairy intake and diabetes incidence, GAD65Ab-negative

HR (95% CI 0.94, 1.02); not associated
0.98

Low dairy intake and diabetes incidence, GAD65Ab-positive

HR (95% CI 0.79, 1.18); not associated
0.97

Original publication

Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study. Diabetologia. Published 10 June 2023. doi:10.1007/s00125-023-05948-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.